Andrea Marmiroli
Overview
Explore the profile of Andrea Marmiroli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
33
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Falkenbach F, Penaranda N, Longoni M, Marmiroli A, Le Q, Catanzaro C, et al.
Int J Urol
. 2025 Mar;
PMID: 40084789
Objective: Radical prostatectomy (RP) may be a treatment option for prostate cancer in patients with chronic kidney disease (CKD). However, the effect of CKD on adverse in-hospital outcomes after RP...
2.
Falkenbach F, Penaranda N, Longoni M, Marmiroli A, Le Q, Catanzaro C, et al.
Urol Oncol
. 2025 Mar;
PMID: 40059014
Introduction: Radical prostatectomy (RP) may be a treatment option for prostate cancer patients with cirrhosis and liver disease (CLD). However, the effect of CLD on adverse in-hospital outcomes after RP...
3.
Longoni M, Penaranda N, Marmiroli A, Falkenbach F, Le Q, Nicolazzini M, et al.
Urology
. 2025 Mar;
PMID: 40057122
Objective: To investigate whether bimodal therapy (BMT) or trimodal therapy (TMT) differ from radical cystectomy (RC) + perioperative chemotherapy (CT) in cancer control outcomes among patients with non-organ-confined (NOC; T3-4...
4.
Nicolazzini M, Penaranda N, Falkenbach F, Longoni M, Marmiroli A, Le Q, et al.
World J Urol
. 2025 Mar;
43(1):149.
PMID: 40044881
Purpose: Chronic kidney disease (CKD) is frequent in bladder cancer patients undergoing radical cystectomy (RC) with ileal conduit. However, the effect of CKD on adverse in-hospital outcomes after ileal conduit...
5.
Penaranda N, Di Bello F, Falkenbach F, Marmiroli A, Longoni M, Le Q, et al.
J Racial Ethn Health Disparities
. 2025 Mar;
PMID: 40035954
Objective: Previously, African American race/ethnicity predisposed to higher rate of adverse in-hospital outcomes after radical cystectomy (RC). We tested whether this association applies to contemporary RC patients. Methods: Patients were...
6.
Longoni M, Di Bello F, Penaranda N, Falkenbach F, Marmiroli A, Le Q, et al.
Clin Genitourin Cancer
. 2025 Jan;
23(2):102300.
PMID: 39863496
Introduction: In NCCN favorable intermediate-risk (FIR) prostate cancer (PCa) patients treated with radical prostatectomy (RP), we tested the effect of upstaging and upgrading on cancer-specific mortality (CSM). Methods: Within the...
7.
Di Bello F, Penaranda N, Marmiroli A, Longoni M, Falkenbach F, Le Q, et al.
J Endourol
. 2025 Jan;
39(2):127-134.
PMID: 39829349
To test whether the contemporary robot-assisted nephroureterectomy (RNU) is associated with more favorable in-hospital outcomes than historical RNU, relative to the same endpoints in open NU (ONU). Within the National...
8.
Penaranda N, Di Bello F, Marmiroli A, Falkenbach F, Longoni M, Le Q, et al.
Ann Surg Oncol
. 2024 Dec;
32(3):2243-2244.
PMID: 39730962
No abstract available.
9.
Longoni M, Di Bello F, Penaranda N, Falkenbach F, Marmiroli A, Le Q, et al.
BJU Int
. 2024 Dec;
PMID: 39667393
Objectives: It is not known whether cancer-specific mortality (CSM) differences distinguish radical cystectomy (RC) from trimodal therapy (TMT) in octogenarians harbouring organ-confined (T2N0M0) urothelial cancer of the urinary bladder (UCUB)....
10.
Penaranda N, Di Bello F, Marmiroli A, Falkenbach F, Longoni M, Le Q, et al.
Ann Surg Oncol
. 2024 Dec;
32(3):2233-2240.
PMID: 39656392
Objective: This study aimed to compare adverse in-hospital outcomes in ileal conduit versus neobladder urinary diversion type after radical cystectomy (RC) in contemporary versus historical patients. Methods: Patients were identified...